摘要
本文报道了1例宫颈癌患者多程治疗后复发转移合并甲状腺黏膜相关淋巴组织淋巴瘤的患者,在使用化疗联合程序性细胞死亡蛋白抑制剂后获益良好,并据此进行文献复习,探讨了该类双重恶性肿瘤的治疗模式。
We reported a case of cervical cancer with recurrence and metastasis accompanied with thyroid mucosa-associated lymphoid tissue(MALT)lymphoma after multiple treatment.The patient benefited well from chemotherapy combined with programmed death-1(PD-1)inhibitor.Literature review was conducted to discussthe treatment method for this type of dual malignancy.
作者
高煜欣
李睿
龙宇
李娇
唐建宁
谭蕊蓉
卢进
Gao Yuxin;Li Rui;Long Yu;Li Jiao;Tang Jianning;Tan Ruirong;Lu Jin(Department of Medical Oncology,Sichuan Cancer Hospital&Institute,Sichuan Cancer Center,School of Medicine,University of Electronic Science and Technology of China,Chengdu 610041,Sichuan,China;Radiotherapy Center,Sichuan Cancer Hospital&Institute,Sichuan Cancer Center,School of Medicine,University of Electronic Science and Technology of China,Chengdu 610041,Sichuan,China;West China School of Pharmacy,Sichuan University,Chengdu 610041,Sichuan,China;Sichuan Center for Translational Chinese Medicine or Sichuan Provincial Key Laboratory of Translational Chinese Medicine,Chengdu 610041,Sichuan,China)
出处
《肿瘤预防与治疗》
2022年第9期829-834,共6页
Journal of Cancer Control And Treatment
基金
四川省肿瘤医院优秀青年基金(编号:YB2021035)
电子科技大学-四川省肿瘤医院肿瘤医工创新基金(编号:ZYGX2021YGCX020)。
